These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 2575792
1. Drug therapy of reflux oesophagitis: an update. Tytgat GN. Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792 [Abstract] [Full Text] [Related]
3. The medical therapy of reflux oesophagitis. Tytgat GN, Nio CY. Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523 [Abstract] [Full Text] [Related]
4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Hatlebakk JG, Berstad A. Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586 [Abstract] [Full Text] [Related]
5. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW. Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [Abstract] [Full Text] [Related]
6. [Conservative therapy of reflux esophagitis]. Koop H. Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350 [No Abstract] [Full Text] [Related]
13. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. Carrasco Gandía S, Lama Moré R, Prieto Bozano G, Polanco Allue I. An Esp Pediatr; 1990 Jun 15; 32(6):485-8. PubMed ID: 2221622 [Abstract] [Full Text] [Related]
14. The current status of gastric prokinetic drugs. Schapira M, Henrion J, Heller FR. Acta Gastroenterol Belg; 1990 Jun 15; 53(4):446-57. PubMed ID: 1982914 [Abstract] [Full Text] [Related]
15. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis. Collins BJ, Spence RA, Ferguson R, Laird J, Love AH. Hepatogastroenterology; 1987 Jun 15; 34(3):113-6. PubMed ID: 3301606 [Abstract] [Full Text] [Related]
16. Pathophysiology and treatment of gastro-oesophageal reflux disease. Vantrappen G, Janssens J. Scand J Gastroenterol Suppl; 1989 Jun 15; 165():7-12; discussion 27-8. PubMed ID: 2574907 [Abstract] [Full Text] [Related]
17. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. Garnett WR. Am J Hosp Pharm; 1993 Apr 15; 50(4 Suppl 1):S11-8. PubMed ID: 8097363 [Abstract] [Full Text] [Related]
18. Medical management of reflux esophagitis. Vantrappen G, Janssens J. Digestion; 1985 Apr 15; 32 Suppl 1():51-8. PubMed ID: 2866136 [Abstract] [Full Text] [Related]
19. The medical management of reflux esophagitis. Role of antacids and acid inhibition. Sontag SJ. Gastroenterol Clin North Am; 1990 Sep 15; 19(3):683-712. PubMed ID: 1977703 [Abstract] [Full Text] [Related]
20. [Internal medicine therapy in reflux disease]. Flad J. Praxis (Bern 1994); 1996 Nov 05; 85(45):1432-8. PubMed ID: 8975352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]